NCT04188236

Safety and Performance of a Hernia Blocking System

Completed NA Last updated 18 October 2023

What this trial tests

NA trial testing Hernia Blocking System in Disk Herniated Lumbar in 30 participants. Completed in 26 June 2023.

Timeline

23 October 2019

Primary endpoint
26 June 2023

26 June 2023

Quick facts

Lead sponsor	NEOS Surgery
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	23 October 2019
Primary completion	26 June 2023
Estimated completion	26 June 2023
Sites	6 locations across Spain

Drugs / interventions tested

• Hernia Blocking System

Conditions studied

• Disk Herniated Lumbar — all drugs for Disk Herniated Lumbar →

Sponsor

NEOS Surgery

Who can join

Adults 18 to 75, any sex, with Disk Herniated Lumbar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, multi-center, single-arm clinical study to assess the performance of an Hernia Blocking System in preventing clinically symptomatic recurrent lumbar disc herniation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. A new hernia blocking system to prevent recurrent lumbar disc herniation: surgical technique, intraoperative findings and six-months post-operative outcomes.
   Godino O, Fernandez-Carballal C, Català I, Moreno Á, et al · · 2025 · cited 4× · PMID 39648196 · DOI 10.1007/s00586-024-08595-x
2. A new hernia blocking system prevents lumbar disc herniation recurrence and disc degeneration: 2 years results of a multicentric clinical investigation.
   Català I, Roldán H, Fernández-Carballal C, Domínguez-Alonso C, et al · · 2026 · PMID 41492501 · DOI 10.1016/j.bas.2025.105898